The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B-1 receptors

被引:39
作者
Meini, S
Lecci, A
Maggi, CA
机构
[1] Pharmacology Department, A. Menarini Pharmaceuticals, 50131, Florence
关键词
kinins; bradykinin B-1 receptor; des-Arg(9)]-BK; (rat) ileum; des-Arg(10)]-Hoe 140; Leu(8);
D O I
10.1111/j.1476-5381.1996.tb15331.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Various bradykinin derivatives, acting preferentially at B-1 or B-2 receptors, were tested in the isolated longitudinal smooth muscle of rat ileum. Experiments were carried out in the presence of chlorpheniramine and atropine (both 1 mu M), guanethidine and indomethacin (both 3 mu M) and of the peptidase inhibitors (captopril, bestatin and thiorphan, all 1 mu M). 2 The rank order of potency was (pD(2) values+/-s.e.mean, n = 5 in parentheses, at 5 h from set-up): [des-Arg(9)]-BK (8.27+/-0.11)greater than or equal to [des-Arg(10)]-kallidin (7.67+/-0.24) > bradykinin (6.69+/-0.25). The B-2 receptor selective agonist, [Hyp(3),Tyr(Me)(8)]-BK, was approximately 10 fold less active than bradykinin. Contractile responses to all agonists increased with time. The maximal response to the B-1 receptor agonist, [desArg(9)]-BK at 5 h (94+/-2%) was significantly (P<0.05) greater than that measured at 2 h (74+/-2%). 3 The B-2 receptor antagonist, D-Arg[Hyp(3), Thi(5), D-Tic(7), Oic(8)]-BK (Hoe 140, 0.1 mu M) did not affect responses to the B-1 receptor agonist [des-Arg(9)]-BK (0.1 nM-1 mu M) nor those to the B-2 receptor agonist, [Hyp(3),Tyr(Me)(8)]-BK (1 nM-10 mu M). In control experiments performed in the longitudinal smooth muscle of guinea-pig ileum and rat isolated urinary bladder as bioassays for B-2 receptors, the B-2 receptor antagonist Hoe 140 (0.1 mu M) antagonized bradykinin-induced contractions. 4 In the rat isolated ileum the B-1 receptor antagonist, D-Arg[Hyp(3), Thi(5), D-Tic(7), Oic(8), des-Arg(9)]-BK ([des-Arg(10)]-Hoe 140, 0.3-10 mu M) competitively antagonized contractile responses to [des-Arg(9)]-BK with an estimated pK(B) of 6.74+/-0.08 (Schild plot slope with confidence limits 1.22, (0.70-1.73) n=13). In control experiments in the guinea-pig isolated ileum and rat isolated urinary bladder, [des-Arg(10)]-Hoe 140 (1-10 mu M) did not inhibit B-2 receptor-mediated contractile responses. 5 The putative B-1 receptor antagonist, [Leu(8),des-Arg(9)]-BK, behaved as a partial agonist when responses were determined 2 h from set-up (pD(2) 6.43+/-0.21, n = 5; E(max) 30% of that evoked by [des-Arg(9)]-BK); at 5 h from set-up it behaved as a full agonist (pD(2) 7.48+/-0.12, n= 5; E(max) 90% of that evoked by [des-Arg(9)]-BK). At this time the response to [Leu(8),des-Arg(9)]-BK was antagonized in a concentration-dependent manner by [des-Arg(10)]-Hoe 140, which at 1 mu M and 10 mu M, produced dose-ratios of 6.33+/-3.66 (n = 4) and 103+/-40 (n = 4). 6 In view of the rank order of potency of agonists, the antagonist activity by [des-Arg(10)]-Hoe 140 and the lack of antagonist activity of Hoe 140, we conclude that the longitudinal smooth muscle of rat ileum, after histamine, acetylcholine, noradrenaline, and prostanoid production blockade, is a sensitive monoreceptor assay for studying the pharmacology of bradykinin B-1 receptors. Further the preparation can also be used as a sensitive bioassay to identify partial agonist activity of B-1 receptor antagonists such as [Leu(8),desArg(9)]-BK.
引用
收藏
页码:1619 / 1624
页数:6
相关论文
共 36 条
[1]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[2]   NITRIC-OXIDE CAUSES CONTRACTION IN THE RAT ISOLATED SMALL-INTESTINE [J].
BARTHO, L ;
LEFEBRE, RA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 259 (01) :101-104
[3]   FURTHER EVIDENCE FOR THE EXISTENCE OF 2 RECEPTOR-SITES FOR BRADYKININ RESPONSIBLE FOR THE DIPHASIC EFFECT IN THE RAT ISOLATED DUODENUM [J].
BOSCHCOV, P ;
PAIVA, ACM ;
PAIVA, TB ;
SHIMUTA, SI .
BRITISH JOURNAL OF PHARMACOLOGY, 1984, 83 (02) :591-600
[4]   STUDIES ON THE INDUCTION OF PHARMACOLOGICAL RESPONSES TO DES-ARG9-BRADYKININ INVITRO AND INVIVO [J].
BOUTHILLIER, J ;
DEBLOIS, D ;
MARCEAU, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (02) :257-264
[5]  
BOXALL SJ, 1995, BRIT J PHARMACOL, V114, pP225
[6]   BRADYKININ B-1 RECEPTORS IN THE RABBIT URINARY-BLADDER - INDUCTION OF RESPONSES, SMOOTH-MUSCLE CONTRACTION, AND PHOSPHATIDYLINOSITOL HYDROLYSIS [J].
BUTT, SK ;
DAWSON, LG ;
HALL, JM .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (03) :612-617
[7]   CARBOXYPEPTIDASE-N (KININASE-I) ACTIVITY IN BLOOD AND SYNOVIAL-FLUID FROM PATIENTS WITH ARTHRITIS [J].
CHERCUITTE, F ;
BEAULIEU, AD ;
POUBELLE, P ;
MARCEAU, F .
LIFE SCIENCES, 1987, 41 (10) :1225-1232
[8]   INDUCTION OF B1 RECEPTORS IN-VIVO IN A MODEL OF PERSISTENT INFLAMMATORY MECHANICAL HYPERALGESIA IN THE RAT [J].
DAVIS, AJ ;
PERKINS, MN .
NEUROPHARMACOLOGY, 1994, 33 (01) :127-133
[9]   EFFECT OF GLUCOCORTICOIDS, MONOKINES AND GROWTH-FACTORS ON THE SPONTANEOUSLY DEVELOPING RESPONSES OF THE RABBIT ISOLATED AORTA TO DES-ARG9-BRADYKININ [J].
DEBLOIS, D ;
BOUTHILLIER, J ;
MARCEAU, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (04) :969-977
[10]   PULSE EXPOSURE TO PROTEIN-SYNTHESIS INHIBITORS ENHANCES VASCULAR-RESPONSES TO DES-ARG9-BRADYKININ - POSSIBLE ROLE OF INTERLEUKIN-1 [J].
DEBLOIS, D ;
BOUTHILLIER, J ;
MARCEAU, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (01) :1057-1066